Voyager: Scaling Defence Momentum, Starlab Optionality Remains

Record $266M backlog and a $1.6B pipeline tied to programs like Golden Dome position Voyager to benefit from accelerating defense spending. FY25 revenue grew 15%, but the company reported a $116.1M net loss and -$155M free cash flow; shares trade at a 6.2x trailing sales premium reflecting market confidence in backlog conversion and Starlab upside.

Analysis

The incremental defense budget tailwind disproportionately benefits downstream systems integrators that sit on program-specific IP and near-term awards rather than commodity suppliers. VOYG’s commercial optionality (space infrastructure programs) amplifies upside if multi-year programs hit milestone payments, but that same optionality concentrates execution risk into discrete certification and integration gates where delays cascade into cash burn and financing events.

Second-order supply-chain winners include RF subsystem vendors, radiation-hardened electronics suppliers, and specialized test/lab services—firms with long lead times that can command price and delivery priority; conversely, general-purpose COTS vendors and small launch integrators risk being commoditized or dropped as primes triage vendor pools. Expect higher working-capital drawdowns and inventory buildups across the chain in the 6–18 month window as long-lead items are procured early to meet program schedules.

Key catalysts are funding/award confirmations and program milestone receipts (months → quarters), while primary risks are contract deferrals, DoD reprioritization, and an equity-financing event that dilutes current holders (near-term). The market currently prices successful conversion; a disciplined, staged exposure that hedges capital-raise risk is the practical way to capture upside without bearing binary downside from missed milestones.

Key Decisions for Investors

• Buy VOYG Jan 2027 LEAP call spread (long LEAP call / sell higher strike) sized as a 2–3% portfolio position to capture multi-year program conversion while capping premium; target 2.5–4x payoff if milestones and funding materialize, max loss = paid premium, horizon 18–36 months.
• Establish a protective hedge: buy 6–12 month VOYG puts 15–25% OTM (or collars if owning stock) to guard against a financing-driven 30–50% drawdown caused by missed milestones or a capital raise; cost should be treated as insurance for idiosyncratic tail risk.
• Pair trade: go long VOYG equity (smaller size) and short an equal-dollar position in a large prime (e.g., LMT or RTX) over 9–12 months to express asymmetric upside from program win conversion while neutralizing broader defense-cyclical beta; rebalance on award announcements or if RFP outcomes skew.
• If VOYG pulls back ≥15% intra-quarter, scale into shares incrementally (staged buys over 3 tranches) and reduce options hedge size—this captures higher expected return-to-cost while keeping downside protection intact; set stop if pullback exceeds 35% without new funding clarity.